GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Algernon Pharmaceuticals Inc (XCNQ:AGN) » Definitions » NonCurrent Deferred Income Tax

Algernon Pharmaceuticals (XCNQ:AGN) NonCurrent Deferred Income Tax : C$0.00 Mil (As of Nov. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Algernon Pharmaceuticals NonCurrent Deferred Income Tax?

Non-Current Deferred Income Tax represents the non-current portion of deferred income taxes, which is the difference in income recognition between tax laws and the accounting methods.

Algernon Pharmaceuticals's non-current deferred income tax for the quarter that ended in Nov. 2024 was C$0.00 Mil.

Algernon Pharmaceuticals NonCurrent Deferred Income Tax Historical Data

The historical data trend for Algernon Pharmaceuticals's NonCurrent Deferred Income Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Algernon Pharmaceuticals NonCurrent Deferred Income Tax Chart

Algernon Pharmaceuticals Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24
NonCurrent Deferred Income Tax
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Algernon Pharmaceuticals Quarterly Data
Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24
NonCurrent Deferred Income Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Algernon Pharmaceuticals NonCurrent Deferred Income Tax Related Terms

Thank you for viewing the detailed overview of Algernon Pharmaceuticals's NonCurrent Deferred Income Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Algernon Pharmaceuticals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Algernon Pharmaceuticals Inc (XCNQ:AGN) » Definitions » NonCurrent Deferred Income Tax
Comparable Companies
XCNQ:ENBI XCNQ:MYND XCNQ:HEAL TSXV:QPT XCNQ:NIRV XCNQ:MBIO TSX:APLI TSXV:XRTX XCNQ:RIZE XCNQ:NSHS VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
AGNPF:USA AGW0:Germany
Address
601 West Broadway, Suite 400, Vancouver, BC, CAN, V5Z 4C2
Website
https://www.algernonpharmaceuticals.com
Algernon Pharmaceuticals Inc is a clinical-stage drug development company focused on the disease areas of stroke, idiopathic pulmonary fibrosis, and chronic cough. The company's business model is capital efficient and strives to deliver maximum shareholder value. Algernon's approach to drug discovery is based on the concept of drug repurposing. It operates in two reportable segments: the development of repurposed therapeutic drugs in Canada, and the facilitation of the Company's drug candidates into off-label phase II clinical trials (humans) in Australia.
Executives
Christopher Moreau Director, Senior Officer
Christopher Scott Bryan Senior Officer
James Kinley Senior Officer
Harry J.f. Bloomfield Director
Rajpaul Attariwala Director
Mark Williams Director
Howard Gutman Director
Michael Sadhra Senior Officer
Kulwant Malhi 10% Security Holder

Algernon Pharmaceuticals Headlines

No Headlines